HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer

Bookmark and Share
Published: 7 Feb 2023
Views: 103
Rating:
Save
Prof Aleix Prat - Hospital Clínic Barcelona, Barcelona, Spain

Prof Prof Aleix Prat speaks to ecancer about his talk at BGICC 2023 on HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer.

He explains that HER2DX is a new assay that is the result of 10 years of research in early-stage HER2 positive breast cancer.

Prof Prat then outlines the three types of information that HER2DX can provide for oncologists.